Halozyme Therapeutics Inc. buy Morgan Stanley
Start price
12.05.26
/
50%
€62.02
Target price
12.05.27
€79.10
Performance (%)
47.89%
Price
08:23
€91.72
Summary
This prediction is currently active. With a performance of 47.89% the BUY prediction by Morgan_Stanley is a big success. This prediction currently runs until 12.05.27. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Halozyme Therapeutics Inc. | 4.302% | 4.302% |
| iShares Core DAX® | -1.059% | 5.007% |
| iShares Nasdaq 100 | -2.387% | 0.864% |
| iShares Nikkei 225® | -4.361% | 1.211% |
| iShares S&P 500 | -1.778% | 1.391% |
Comments by Morgan_Stanley for this prediction
In the thread Halozyme Therapeutics Inc. diskutieren
Halozyme Therapeutics (HALO) had its price target lowered by Morgan Stanley from $96.00 to $93.00. They now have an "overweight" rating on the stock.
Ratings data for HALO provided by MarketBeat
Stopped prediction by Morgan_Stanley for Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€57.80
20.10.25
20.10.25
€67.75
20.10.26
20.10.26
58.69%
08:23
08:23
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€58.38
18.08.25
18.08.25
€68.36
18.08.26
18.08.26
55.22%
19.08.26
19.08.26
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€54.00
06.08.25
06.08.25
€64.83
06.08.26
06.08.26
44.63%
07.08.26
07.08.26
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€49.79
07.08.24
07.08.24
€58.59
07.08.25
07.08.25
6.69%
08.08.25
08.08.25
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€34.03
26.12.23
26.12.23
€53.50
26.12.24
26.12.24
34.94%
27.12.24
27.12.24
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€40.11
10.08.23
10.08.23
€55.35
10.08.24
10.08.24
26.55%
11.08.24
11.08.24
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€42.50
06.03.23
06.03.23
€60.06
06.03.24
06.03.24
-10.61%
07.03.24
07.03.24